Indian Doctors Discover World’s Rarest Blood Group CRIB

Summary:
Indian doctors have discovered a new and extremely rare blood group called CRIB, which is now considered the rarest in the world. Eminent during testing in Gujarat, this blood type lacks all known antigens, which are facing major challenges for transfusion. This discovery has global importance for medical research and rare donor registries. 

In a groundbreaking development in the field of hematology, Indian doctors have now identified an unknown blood group cradle which is now considered rare in the world. The discovery was done during a regular testing at a hospital in Gujarat, India, where a patient’s blood sample failed to match any existing blood group systems. 

After extensive testing and genetic analysis, scientists confirmed that the patient had a completely new blood antigen profile, leading to the classification of a new group called CRIB – a brief name inspired by unique cellular markers found in red blood cells. Medical experts believe that this may be a one-time generation discovery. 

What Makes CRIB So Rare? 

CRIB blood contains all commonly known antigens in major blood group systems including ABO, Rh and even rare Bombay phenotypes. This means that people with CRIB blood can neither donate nor get blood from any known group – a major challenge for infections and surgical processes. 

Global Significance 

The discovery is the major implications for transfusion therapy, especially in the context of donor registry expansion, blood compatibility testing and rare blood banking. Researchers from all over the world are now urging us to include cradle in international blood group classification. 

India at the Forefront 

With previous discoveries such as Bombay Blood Group, India has been an important contributor in rare blood group research and is now highlighting the need for more advanced diagnosis. This recent success confirmed India’s position in state -of -the -art medical research. 

Conclusion 

Medical professionals are now working to detect CRIB-positive individual relatives and community members in the hope of identifying other possible carriers. Specific donor registries and genetic counseling may be necessary to support patients with such ultra- rare blood types in the future. 

Source1   

Disclaimer:  

(The views expressed are solely on the basis of research. Indiagnostic shall not be responsible for any damage caused to any person/organization directly or indirectly).